Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Black Diamond Therapeutics (BDTX) Current Assets: 2018-2021

Historic Current Assets for Black Diamond Therapeutics (BDTX) over the last 2 years, with Sep 2021 value amounting to $241.5 million.

  • Black Diamond Therapeutics' Current Assets fell 28.20% to $241.5 million in Q3 2021 from the same period last year, while for Sep 2021 it was $241.5 million, marking a year-over-year decrease of 28.20%. This contributed to the annual value of $319.6 million for FY2020, which is 105.22% up from last year.
  • As of Q3 2021, Black Diamond Therapeutics' Current Assets stood at $241.5 million, which was down 10.85% from $270.9 million recorded in Q2 2021.
  • Black Diamond Therapeutics' 5-year Current Assets high stood at $362.1 million for Q1 2020, and its period low was $51.7 million during Q4 2018.
  • In the last 3 years, Black Diamond Therapeutics' Current Assets had a median value of $284.1 million in 2021 and averaged $274.0 million.
  • In the last 5 years, Black Diamond Therapeutics' Current Assets soared by 201.28% in 2019 and then fell by 28.20% in 2021.
  • Black Diamond Therapeutics' Current Assets (Quarterly) stood at $51.7 million in 2018, then soared by 201.28% to $155.7 million in 2019, then skyrocketed by 105.22% to $319.6 million in 2020, then fell by 28.20% to $241.5 million in 2021.
  • Its Current Assets stands at $241.5 million for Q3 2021, versus $270.9 million for Q2 2021 and $297.3 million for Q1 2021.